▶ 調査レポート

変形性膝関節症用関節内補充療法の世界市場レポート2020

• 英文タイトル:Global Viscosupplementation for Knee Osteoarthritis Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。変形性膝関節症用関節内補充療法の世界市場レポート2020 / Global Viscosupplementation for Knee Osteoarthritis Sales Market Report 2020 / QY20ST-06407資料のイメージです。• レポートコード:QY20ST-06407
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥580,000 (USD4,000)▷ お問い合わせ
  Multi User¥870,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,160,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の変形性膝関節症用関節内補充療法市場について種類別(シングル注射、3回注射、5回注射)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・変形性膝関節症用関節内補充療法市場の概要
・世界の主要地域別変形性膝関節症用関節内補充療法市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の変形性膝関節症用関節内補充療法市場規模2015-2026:種類別(シングル注射、3回注射、5回注射)
・世界の変形性膝関節症用関節内補充療法市場規模2015-2026:用途別(病院、クリニック、その他)
・変形性膝関節症用関節内補充療法の北米市場規模2015-2020
・変形性膝関節症用関節内補充療法のヨーロッパ市場規模2015-2020
・変形性膝関節症用関節内補充療法の中国市場規模2015-2020
・変形性膝関節症用関節内補充療法の日本市場規模2015-2020
・変形性膝関節症用関節内補充療法の東南アジア市場規模2015-2020
・変形性膝関節症用関節内補充療法のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・変形性膝関節症用関節内補充療法の製造コスト分析
・販売チャネル、流通業者、顧客
・変形性膝関節症用関節内補充療法の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Viscosupplementation for Knee Osteoarthritis Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Viscosupplementation for Knee Osteoarthritis market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Viscosupplementation for Knee Osteoarthritis market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Viscosupplementation for Knee Osteoarthritis industry.
Based on our recent survey, we have several different scenarios about the Viscosupplementation for Knee Osteoarthritis YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Viscosupplementation for Knee Osteoarthritis will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Viscosupplementation for Knee Osteoarthritis market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Viscosupplementation for Knee Osteoarthritis market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Viscosupplementation for Knee Osteoarthritis market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Viscosupplementation for Knee Osteoarthritis market. The report also includes nautical information, where it shows Viscosupplementation for Knee Osteoarthritis market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Viscosupplementation for Knee Osteoarthritis market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Viscosupplementation for Knee Osteoarthritis market.
Geographical Analysis:
Based on region, the global Viscosupplementation for Knee Osteoarthritis market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Viscosupplementation for Knee Osteoarthritis market are
Sanofi
Anika Therapeutics
Seikagaku
Zimmer
Bioventus
Ferring
Lifecore Biomedical
LG Life Sciences
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Viscosupplementation for Knee Osteoarthritis market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Viscosupplementation for Knee Osteoarthritis market.
• The market share of the global Viscosupplementation for Knee Osteoarthritis market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Viscosupplementation for Knee Osteoarthritis market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Viscosupplementation for Knee Osteoarthritis market.

レポート目次

1 Viscosupplementation for Knee Osteoarthritis Market Overview
1.1 Viscosupplementation for Knee Osteoarthritis Product Scope
1.2 Viscosupplementation for Knee Osteoarthritis Segment by Type
1.2.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2020-2026)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Viscosupplementation for Knee Osteoarthritis Segment by Application
1.3.1 Global Viscosupplementation for Knee Osteoarthritis Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Viscosupplementation for Knee Osteoarthritis Market Estimates and Forecasts (2015-2026)
1.4.1 Global Viscosupplementation for Knee Osteoarthritis Sales Growth Rate (2015-2026)
1.4.2 Global Viscosupplementation for Knee Osteoarthritis Revenue and Growth Rate (2015-2026)
1.4.3 Global Viscosupplementation for Knee Osteoarthritis Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Viscosupplementation for Knee Osteoarthritis Industry Impact
1.5.1 How the Covid-19 is Affecting the Viscosupplementation for Knee Osteoarthritis Industry
1.5.1.1 Viscosupplementation for Knee Osteoarthritis Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Viscosupplementation for Knee Osteoarthritis Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Viscosupplementation for Knee Osteoarthritis Players to Combat Covid-19 Impact

2 Viscosupplementation for Knee Osteoarthritis Estimate and Forecast by Region
2.1 Global Viscosupplementation for Knee Osteoarthritis Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Viscosupplementation for Knee Osteoarthritis Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2015-2020)
2.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region (2015-2020)
2.3 Global Viscosupplementation for Knee Osteoarthritis Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Viscosupplementation for Knee Osteoarthritis Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
2.4.2 Europe Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
2.4.3 China Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
2.4.4 Japan Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
2.4.6 India Viscosupplementation for Knee Osteoarthritis Estimates and Projections (2015-2026)
3 Global Viscosupplementation for Knee Osteoarthritis Competition Landscape by Players
3.1 Global Top Viscosupplementation for Knee Osteoarthritis Players by Sales (2015-2020)
3.2 Global Top Viscosupplementation for Knee Osteoarthritis Players by Revenue (2015-2020)
3.3 Global Viscosupplementation for Knee Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viscosupplementation for Knee Osteoarthritis as of 2019)
3.4 Global Viscosupplementation for Knee Osteoarthritis Average Price by Company (2015-2020)
3.5 Manufacturers Viscosupplementation for Knee Osteoarthritis Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Viscosupplementation for Knee Osteoarthritis Players (Opinion Leaders)
4 Global Viscosupplementation for Knee Osteoarthritis Market Size by Type
4.1 Global Viscosupplementation for Knee Osteoarthritis Historic Market Review by Type (2015-2020)
4.1.1 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
4.1.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2015-2020)
4.1.3 Global Viscosupplementation for Knee Osteoarthritis Price by Type (2014-2020)
4.2 Global Viscosupplementation for Knee Osteoarthritis Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Viscosupplementation for Knee Osteoarthritis Sales Forecast by Type (2021-2026)
4.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Type (2021-2026)
4.2.3 Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Type (2021-2026)
5 Global Viscosupplementation for Knee Osteoarthritis Market Size by Application
5.1 Global Viscosupplementation for Knee Osteoarthritis Historic Market Review by Application (2015-2020)
5.1.1 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
5.1.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2015-2020)
5.1.3 Global Viscosupplementation for Knee Osteoarthritis Price by Application (2015-2020)
5.2 Global Viscosupplementation for Knee Osteoarthritis Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Viscosupplementation for Knee Osteoarthritis Sales Forecast by Application (2021-2026)
5.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Application (2021-2026)
5.2.3 Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Application (2021-2026)

3 North America Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
3.2 North America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
3.3 North America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
3.4 North America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

4 Europe Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
4.2 Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
4.3 Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
4.4 Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

5 China Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
5.2 China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
5.3 China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
5.4 China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

6 Japan Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
6.2 Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
6.3 Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
6.4 Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

7 Southeast Asia Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
7.2 Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

8 India Viscosupplementation for Knee Osteoarthritis Market Facts & Figures
8.2 India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
8.3 India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
8.4 India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Viscosupplementation for Knee Osteoarthritis Business
12.1 Sanofi
12.1.1 Sanofi Viscosupplementation for Knee Osteoarthritis Corporation Information
12.1.2 Sanofi Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.1.3 Sanofi Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Viscosupplementation for Knee Osteoarthritis Products Offered
12.1.5 Sanofi Recent Development
12.2 Anika Therapeutics
12.2.1 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Corporation Information
12.2.2 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.2.3 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Products Offered
12.2.5 Anika Therapeutics Recent Development
12.3 Seikagaku
12.3.1 Seikagaku Viscosupplementation for Knee Osteoarthritis Corporation Information
12.3.2 Seikagaku Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.3.3 Seikagaku Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Seikagaku Viscosupplementation for Knee Osteoarthritis Products Offered
12.3.5 Seikagaku Recent Development
12.4 Zimmer
12.4.1 Zimmer Viscosupplementation for Knee Osteoarthritis Corporation Information
12.4.2 Zimmer Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.4.3 Zimmer Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zimmer Viscosupplementation for Knee Osteoarthritis Products Offered
12.4.5 Zimmer Recent Development
12.5 Bioventus
12.5.1 Bioventus Viscosupplementation for Knee Osteoarthritis Corporation Information
12.5.2 Bioventus Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.5.3 Bioventus Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bioventus Viscosupplementation for Knee Osteoarthritis Products Offered
12.5.5 Bioventus Recent Development
12.6 Ferring
12.6.1 Ferring Viscosupplementation for Knee Osteoarthritis Corporation Information
12.6.2 Ferring Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.6.3 Ferring Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ferring Viscosupplementation for Knee Osteoarthritis Products Offered
12.6.5 Ferring Recent Development
12.7 Lifecore Biomedical
12.7.1 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Corporation Information
12.7.2 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.7.3 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Products Offered
12.7.5 Lifecore Biomedical Recent Development
12.8 LG Life Sciences
12.8.1 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Corporation Information
12.8.2 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Business Overview and Total Revenue
12.8.3 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2015-2020)
12.8.4 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Products Offered
12.8.5 LG Life Sciences Recent Development

13 Viscosupplementation for Knee Osteoarthritis Manufacturing Cost Analysis
13.1 Viscosupplementation for Knee Osteoarthritis Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Viscosupplementation for Knee Osteoarthritis
13.4 Viscosupplementation for Knee Osteoarthritis Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Viscosupplementation for Knee Osteoarthritis Distributors List
14.3 Viscosupplementation for Knee Osteoarthritis Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Viscosupplementation for Knee Osteoarthritis Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Viscosupplementation for Knee Osteoarthritis Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Viscosupplementation for Knee Osteoarthritis Players to Combat Covid-19 Impact
Table 8. Global Market Viscosupplementation for Knee Osteoarthritis Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Region (2015-2020)
Table 10. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2015-2020)
Table 11. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Region (2015-2020)
Table 13. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Viscosupplementation for Knee Osteoarthritis Revenue Share Forecast by Region (2021-2026)
Table 17. Global Viscosupplementation for Knee Osteoarthritis (K Units) of Key Companies (2015-2020)
Table 18. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Company (2015-2020)
Table 19. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Company (2015-2020)
Table 21. Global Viscosupplementation for Knee Osteoarthritis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viscosupplementation for Knee Osteoarthritis as of 2019)
Table 22. Global Viscosupplementation for Knee Osteoarthritis Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Viscosupplementation for Knee Osteoarthritis Manufacturing Sites and Area Served
Table 24. Manufacturers Viscosupplementation for Knee Osteoarthritis Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Viscosupplementation for Knee Osteoarthritis Players
Table 27. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 28. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Type (2015-2020)
Table 29. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Viscosupplementation for Knee Osteoarthritis Price (K Units) by Type (2015-2020)
Table 31. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Type (2021-2026)
Table 32. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Type (2021-2026)
Table 34. Global Viscosupplementation for Knee Osteoarthritis Price (K Units) by Type (2021-2026)
Table 35. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 36. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Application (2015-2020)
Table 37. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Viscosupplementation for Knee Osteoarthritis Price (K Units) by Application (2015-2020)
Table 39. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2021-2026)
Table 40. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Application (2021-2026)
Table 41. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Application (2021-2026)
Table 43. Global Viscosupplementation for Knee Osteoarthritis Price (K Units) by Application (2021-2026)
Table 44. United States Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 45. United States Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 46. United States Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 47. United States Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 48. United States Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 49. United States Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
Table 50. Europe Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 51. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 52. Europe Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 53. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 54. Europe Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 55. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 56. China Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 57. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 58. China Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 59. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 60. China Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 61. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
Table 62. Japan Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 63. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 64. Japan Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 65. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 66. Japan Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 67. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
Table 74. India Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Company (2015-2020)
Table 75. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2015-2020)
Table 76. India Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Type (2015-2020)
Table 77. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2015-2020)
Table 78. India Viscosupplementation for Knee Osteoarthritis Sales (K Units) by Application (2015-2020)
Table 79. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Viscosupplementation for Knee Osteoarthritis Product
Table 84. Sanofi Recent Development
Table 85. Anika Therapeutics Corporation Information
Table 86. Anika Therapeutics Description and Business Overview
Table 87. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product
Table 89. Anika Therapeutics Recent Development
Table 90. Seikagaku Corporation Information
Table 91. Seikagaku Description and Business Overview
Table 92. Seikagaku Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Seikagaku Viscosupplementation for Knee Osteoarthritis Product
Table 94. Seikagaku Recent Development
Table 95. Zimmer Corporation Information
Table 96. Zimmer Description and Business Overview
Table 97. Zimmer Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Zimmer Viscosupplementation for Knee Osteoarthritis Product
Table 99. Zimmer Recent Development
Table 100. Bioventus Corporation Information
Table 101. Bioventus Description and Business Overview
Table 102. Bioventus Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bioventus Viscosupplementation for Knee Osteoarthritis Product
Table 104. Bioventus Recent Development
Table 105. Ferring Corporation Information
Table 106. Ferring Description and Business Overview
Table 107. Ferring Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Ferring Viscosupplementation for Knee Osteoarthritis Product
Table 109. Ferring Recent Development
Table 110. Lifecore Biomedical Corporation Information
Table 111. Lifecore Biomedical Description and Business Overview
Table 112. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Product
Table 114. Lifecore Biomedical Recent Development
Table . LG Life Sciences Corporation Information
Table . LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . LG Life Sciences Description and Business Overview
Table . LG Life Sciences Viscosupplementation for Knee Osteoarthritis Product
Table . LG Life Sciences Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Viscosupplementation for Knee Osteoarthritis Distributors List
Table 123. Viscosupplementation for Knee Osteoarthritis Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Viscosupplementation for Knee Osteoarthritis Product Picture
Figure 2. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Viscosupplementation for Knee Osteoarthritis Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Viscosupplementation for Knee Osteoarthritis Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Viscosupplementation for Knee Osteoarthritis Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Viscosupplementation for Knee Osteoarthritis Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Viscosupplementation for Knee Osteoarthritis Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Viscosupplementation for Knee Osteoarthritis Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Viscosupplementation for Knee Osteoarthritis Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Viscosupplementation for Knee Osteoarthritis Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Viscosupplementation for Knee Osteoarthritis Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Viscosupplementation for Knee Osteoarthritis Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Viscosupplementation for Knee Osteoarthritis Players Market Share by Revenue in Viscosupplementation for Knee Osteoarthritis 2015 & 2019
Figure 27. Viscosupplementation for Knee Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Type (2015-2020)
Figure 29. Global Viscosupplementation for Knee Osteoarthritis Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Application (2015-2020)
Figure 31. Global Viscosupplementation for Knee Osteoarthritis Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 33. United States Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 34. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company in 2019
Figure 35. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 36. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application in 2019
Figure 37. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company in 2019
Figure 38. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 39. China Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application in 2019
Figure 40. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company in 2019
Figure 41. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 42. Japan Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application in 2019
Figure 43. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company in 2019
Figure 44. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 45. Southeast Asia Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application in 2019
Figure 46. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company in 2019
Figure 47. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2019
Figure 48. India Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application in 2019
Figure 49. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Seikagaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Zimmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bioventus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Lifecore Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Viscosupplementation for Knee Osteoarthritis
Figure 59. Manufacturing Process Analysis of Viscosupplementation for Knee Osteoarthritis
Figure 60. Viscosupplementation for Knee Osteoarthritis Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed